Clinical Trial Update: A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the combination of enzalutamide with trastuzumab in patients with HER2-positive, AR-positive metastatic or locally advanced breast can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Xtandi (enzalutamide)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: HER2 Amplified, Advanced Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-05-16